Vaxart, Inc.

Vaxart, Inc. is a clinical-stage biotechnology company specializing in the development of oral recombinant vaccines based on its proprietary delivery platform. Their vaccines are administered in convenient, room temperature-stable pills that can be stored and shipped without refrigeration, eliminating the need for needles and minimizing the risk of needle-stick injury. This innovative approach has the potential to revolutionize vaccine delivery and distribution, particularly in regions with limited access to cold chain infrastructure. Vaxart's vaccine pipeline includes products designed to protect against common viral infections such as coronavirus, norovirus, and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), their first immuno-oncology indication.

Vaxart's mission is to make the world a better and safer place by developing vaccines that provide stronger, broader, and more durable protection against viral infections. They believe their oral vaccine pills can overcome the public anxiety associated with fast-spreading infections, address the challenges of mass vaccination, and eliminate the expense and inequity of cold chain distribution. By focusing on developing vaccines that are easier and less expensive to distribute, Vaxart aims to improve global health outcomes and accessibility to life-saving treatments.

Vaxart is a clinical-stage biotechnology company dedicated to developing transformative oral vaccines against common viral infections. Their mission is to make the world a better and safer place by creating vaccines that provide stronger, broader, and more durable protection against viral diseases. Their oral pill format offers several advantages over traditional injectable vaccines, including ease of administration, room-temperature stability, and the potential for faster and less expensive distribution.

Vaxart promotes a culture of innovation and collaboration, fueled by a shared passion for improving global public health. They emphasize the importance of teamwork and value the contributions of their scientists, researchers, and vaccine developers. The company is committed to creating a welcoming and inclusive environment where individuals can thrive and contribute to the mission of developing transformative oral vaccines.

Vaxart is committed to building a diverse, equitable, and inclusive workplace where everyone feels valued, respected, and empowered to contribute their unique talents. The company actively seeks to create a culture that embraces a wide range of perspectives, backgrounds, and experiences, recognizing that diversity of thought strengthens innovation and problem-solving. Vaxart fosters a culture of inclusivity through various initiatives, including recruitment and retention programs, employee resource groups, and leadership development opportunities.